Klacid

Clarithromycin, the active ingredient in Klacid, is a macrolide antibiotic presented as an oral tablet for oral use. It treats a range of bacterial infections, including community‑acquired pneumonia, acute bacterial sinusitis, and skin and soft‑tissue infections, in adult patients.

GNH USA supplies Klacid as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable sourcing for global healthcare providers. Our distribution network ensures timely delivery and regulatory compliance across multiple regions.

Clarithromycin is a macrolide antibiotic used to treat infections caused by susceptible bacteria.

Community‑acquired pneumonia: reduces bacterial load and improves clinical outcomes in adult patients. Acute bacterial sinusitis: alleviates sinus inflammation and clears infection. Skin and soft‑tissue infections: eradicates causative organisms and promotes healing. Helicobacter pylori eradication: part of combination therapy to eliminate H. pylori infection.

Clarithromycin may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Gastrointestinal upset: nausea, vomiting, abdominal pain. - Diarrhea: mild to moderate watery stools. - Taste disturbance: altered taste or metallic sensation. - Headache: mild headache.

Serious or Rare Side Effects: - Severe allergic reaction: rash, itching, swelling, or anaphylaxis. - Liver enzyme elevation: hepatitis or jaundice. - Cardiac arrhythmia: QT prolongation leading to torsades de pointes.

When prescribing clarithromycin, clinicians should consider several safety measures.

Assess renal and hepatic function: adjust therapy if significant impairment. Avoid use in patients with known macrolide hypersensitivity: risk of severe allergic response. Monitor QT interval: caution in patients with cardiac conduction disorders or taking other QT‑prolonging drugs. Consider drug interactions: clarithromycin can affect metabolism of concomitant medications. Pregnancy and lactation: category B, use only if benefits outweigh risks. Store at ambient temperature below 25°C: keep in original packaging, protect from moisture and light.

Clarithromycin interacts with several medicines; awareness of interaction severity guides clinical decisions.

Major Interactions (Avoid): - CYP3A4 substrates such as simvastatin or lovastatin: risk of increased plasma levels and myopathy. - Ergot alkaloids (e.g., ergotamine): may cause severe vasospasm. - Pimozide: risk of serious cardiac events due to elevated concentrations.

Moderate Interactions (Monitor Closely): - Warfarin: may enhance anticoagulant effect, monitor INR. - Theophylline: increased levels, monitor for toxicity. - Carbamazepine: reduced efficacy, monitor seizure control.